AURA
Price
$6.09
Change
+$0.33 (+5.73%)
Updated
Oct 8 closing price
Capitalization
378.31M
28 days until earnings call
BSEM
Price
$4.80
Change
-$0.03 (-0.62%)
Updated
Oct 8 closing price
Capitalization
80.28M
40 days until earnings call
Interact to see
Advertisement

AURA vs BSEM

Header iconAURA vs BSEM Comparison
Open Charts AURA vs BSEMBanner chart's image
Aura Biosciences
Price$6.09
Change+$0.33 (+5.73%)
Volume$331.42K
Capitalization378.31M
BioStem Technologies
Price$4.80
Change-$0.03 (-0.62%)
Volume$32.7K
Capitalization80.28M
AURA vs BSEM Comparison Chart in %
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. BSEM commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a StrongBuy and BSEM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (AURA: $6.09 vs. BSEM: $4.80)
Brand notoriety: AURA and BSEM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 159% vs. BSEM: 41%
Market capitalization -- AURA: $378.31M vs. BSEM: $80.28M
AURA [@Biotechnology] is valued at $378.31M. BSEM’s [@Biotechnology] market capitalization is $80.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 1 FA rating(s) are green whileBSEM’s FA Score has 0 green FA rating(s).

  • AURA’s FA Score: 1 green, 4 red.
  • BSEM’s FA Score: 0 green, 5 red.
According to our system of comparison, AURA is a better buy in the long-term than BSEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 3 TA indicator(s) are bullish while BSEM’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 3 bullish, 4 bearish.
  • BSEM’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, BSEM is a better buy in the short-term than AURA.

Price Growth

AURA (@Biotechnology) experienced а -0.98% price change this week, while BSEM (@Biotechnology) price change was -3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

AURA is expected to report earnings on Nov 06, 2025.

BSEM is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($378M) has a higher market cap than BSEM($80.3M). AURA YTD gains are higher at: -25.912 vs. BSEM (-65.318). BSEM has higher annual earnings (EBITDA): -8.62M vs. AURA (-107.51M). AURA has more cash in the bank: 177M vs. BSEM (110K). BSEM has less debt than AURA: BSEM (6.02M) vs AURA (18.1M). BSEM has higher revenues than AURA: BSEM (6.04M) vs AURA (0).
AURABSEMAURA / BSEM
Capitalization378M80.3M471%
EBITDA-107.51M-8.62M1,247%
Gain YTD-25.912-65.31840%
P/E RatioN/A3.27-
Revenue06.04M-
Total Cash177M110K160,909%
Total Debt18.1M6.02M300%
FUNDAMENTALS RATINGS
BSEM: Fundamental Ratings
BSEM
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AURABSEM
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
77%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORFDF0.06N/A
+4.85%
ORECAP INVEST CORP.
CELJF9.71N/A
N/A
Cellcom Israel, Ltd.
SHPMF1.53N/A
N/A
Shanghai Pharmaceuticals Holdings Co., Ltd.
CHHGF0.21N/A
N/A
Chen Hsong Holdings Ltd.
UNLYF58.67-0.72
-1.21%
Unilever, PLC

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VTYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
-0.62%
VTYX - BSEM
22%
Poorly correlated
-3.77%
ABSI - BSEM
20%
Poorly correlated
+11.76%
AURA - BSEM
20%
Poorly correlated
+5.73%
CELU - BSEM
20%
Poorly correlated
+5.39%
CLVLY - BSEM
11%
Poorly correlated
-0.79%
More